These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 8613929

  • 41. Anxiolytic- and antidepressant-like effects of an antagonist at glycineB receptors.
    Przegaliński E, Tatarczyńska E, Chojnacka-Wójcik E.
    Pol J Pharmacol; 1998; 50(4-5):349-54. PubMed ID: 10091720
    [Abstract] [Full Text] [Related]

  • 42. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D, Percival MD, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Falgueyret JP, Ford-Hutchinson AW, Gordon R, Greig G, Gresser M, Guay J, Kargman S, Léger S, Mancini JA, O'Neill G, Ouellet M, Rodger IW, Thérien M, Wang Z, Webb JK, Wong E, Chan CC.
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [Abstract] [Full Text] [Related]

  • 43. Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
    Izumi T, Iwamoto N, Kitaichi Y, Kato A, Inoue T, Koyama T.
    Eur J Pharmacol; 2007 Jun 22; 565(1-3):105-12. PubMed ID: 17400208
    [Abstract] [Full Text] [Related]

  • 44. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.
    Bonaventure P, Kelly L, Aluisio L, Shelton J, Lord B, Galici R, Miller K, Atack J, Lovenberg TW, Dugovic C.
    J Pharmacol Exp Ther; 2007 May 22; 321(2):690-8. PubMed ID: 17314195
    [Abstract] [Full Text] [Related]

  • 45. Cognitive aspects of congenital learned helplessness and its reversal by the monoamine oxidase (MAO)-B inhibitor deprenyl.
    Schulz D, Mirrione MM, Henn FA.
    Neurobiol Learn Mem; 2010 Feb 22; 93(2):291-301. PubMed ID: 19931627
    [Abstract] [Full Text] [Related]

  • 46. Effect of TV3326, a novel monoamine-oxidase cholinesterase inhibitor, in rat models of anxiety and depression.
    Weinstock M, Poltyrev T, Bejar C, Youdim MB.
    Psychopharmacology (Berl); 2002 Mar 22; 160(3):318-24. PubMed ID: 11889501
    [Abstract] [Full Text] [Related]

  • 47. Behavioural profiles of the reversible monoamine-oxidase-A inhibitors befloxatone and moclobemide in an experimental model for screening anxiolytic and anti-panic drugs.
    Griebel G, Perrault G, Sanger DJ.
    Psychopharmacology (Berl); 1997 May 22; 131(2):180-6. PubMed ID: 9201807
    [Abstract] [Full Text] [Related]

  • 48. Moclobemide enhances aversively motivated learning and memory in rats.
    Frank M, Braszko JJ.
    Pol J Pharmacol; 1999 May 22; 51(6):497-503. PubMed ID: 10817527
    [Abstract] [Full Text] [Related]

  • 49. [Neurochemical and behavioral study on the mechanism of the antidepressant and anxiolytic effect of co-administration of lithium and monoamine oxidase inhibitors].
    Kitaichi Y.
    Hokkaido Igaku Zasshi; 2004 Jan 22; 79(1):93-101. PubMed ID: 14978979
    [No Abstract] [Full Text] [Related]

  • 50. Diphenyl diselenide exerts antidepressant-like and anxiolytic-like effects in mice: involvement of L-arginine-nitric oxide-soluble guanylate cyclase pathway in its antidepressant-like action.
    Savegnago L, Jesse CR, Pinto LG, Rocha JB, Barancelli DA, Nogueira CW, Zeni G.
    Pharmacol Biochem Behav; 2008 Feb 22; 88(4):418-26. PubMed ID: 17936885
    [Abstract] [Full Text] [Related]

  • 51. Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action.
    Page ME, Brown K, Lucki I.
    Psychopharmacology (Berl); 2003 Jan 22; 165(2):194-201. PubMed ID: 12426668
    [Abstract] [Full Text] [Related]

  • 52. [The new antidepressant tetrindole].
    Mashkovskiĭ MD, Glushkov RG, Shvedov VI, Andreeva NI, Golovina SM.
    Eksp Klin Farmakol; 1993 Jan 22; 56(2):3-6. PubMed ID: 8348033
    [Abstract] [Full Text] [Related]

  • 53. Effects of befloxatone, a reversible selective monoamine oxidase-A inhibitor, on psychomotor function and memory in healthy subjects.
    Warot D, Berlin I, Patat A, Durrieu G, Zieleniuk I, Puech AJ.
    J Clin Pharmacol; 1996 Oct 22; 36(10):942-50. PubMed ID: 8930782
    [Abstract] [Full Text] [Related]

  • 54. Sedative, anxiolytic and antidepressant activities of Citrus limon (Burn) essential oil in mice.
    L M Lopes C, Gonçalves e Sá C, de Almeida AA, da Costa JP, Marques TH, Feitosa CM, Saldanha GB, de Freitas RM.
    Pharmazie; 2011 Aug 22; 66(8):623-7. PubMed ID: 21901988
    [Abstract] [Full Text] [Related]

  • 55. A reversible monoamine oxidase A inhibitor, befloxatone: structural approach of its mechanism of action.
    Wouters J, Moureau F, Evrard G, Koenig JJ, Jegham S, George P, Durant F.
    Bioorg Med Chem; 1999 Aug 22; 7(8):1683-93. PubMed ID: 10482460
    [Abstract] [Full Text] [Related]

  • 56. Mapping the cerebral monoamine oxidase type A: positron emission tomography characterization of the reversible selective inhibitor [11C]befloxatone.
    Bottlaender M, Dolle F, Guenther I, Roumenov D, Fuseau C, Bramoulle Y, Curet O, Jegham J, Pinquier JL, George P, Valette H.
    J Pharmacol Exp Ther; 2003 May 22; 305(2):467-73. PubMed ID: 12606609
    [Abstract] [Full Text] [Related]

  • 57. New Human Monoamine Oxidase A Inhibitors with Potential Anti- Depressant Activity: Design, Synthesis, Biological Screening and Evaluation of Pharmacological Activity.
    Evranos-Aksoz B, Ucar G, Tas ST, Aksoz E, Yelekci K, Erikci A, Sara Y, Iskit AB.
    Comb Chem High Throughput Screen; 2017 May 22; 20(6):461-473. PubMed ID: 28474547
    [Abstract] [Full Text] [Related]

  • 58. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.
    Worms P, Kan JP, Wermuth CG, Roncucci R, Bizière K.
    J Pharmacol Exp Ther; 1987 Jan 22; 240(1):241-50. PubMed ID: 3100770
    [Abstract] [Full Text] [Related]

  • 59. Psychotropic drugs (2). Interaction between monoamine oxidase (MAO) inhibitors and other substances.
    Sjöqvist F.
    Proc R Soc Med; 1965 Nov 22; 58(11 Part 2):967-78. PubMed ID: 4952963
    [Abstract] [Full Text] [Related]

  • 60. Central effects of Ro 19-6327 given acutely and repeatedly.
    Skuza G, Rogóz Z.
    Pol J Pharmacol Pharm; 1991 Nov 22; 43(6):437-47. PubMed ID: 1668212
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.